Unknown

Dataset Information

0

Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.


ABSTRACT: Constitutive activation of FGFR1, through rearrangement with various dimerization domains, leads to atypical myeloproliferative disorders where, although T cell lymphoma are common, the BCR-FGFR1 chimeric kinase results in CML-like leukemia. As with the human disease, mouse bone marrow transduction/transplantation with BCR-FGFR1 leads to CML-like myeloproliferation as well as B-cell leukemia/lymphoma. The murine disease described in this report is virtually identical to the human disease in that both showed bi-lineage involvement of myeloid and B-cells, splenomegaly, leukocytosis and bone marrow hypercellularity. A CD19(+) IgM(-) CD43(+) immunophenotype was seen both in primary tumors and two cell lines derived from these tumors. In all primary tumors, subpopulations of these CD19(+) IgM(-) CD43(+) were also either B220(+) or B220(-), suggesting a block in differentiation at the pro-B cell stage. The B220(-) phenotype was retained in one of the cell lines while the other was B220(+). When the two cell lines were transplanted into syngeneic mice, all animals developed the same B-lymphoblastic leukemia within 2-weeks. Thus, the murine model described here closely mimics the human disease with bilineage myeloid and B-cell leukemia/lymphoma which provides a representative model to investigate therapeutic intervention and a better understanding of the etiology of the disease.

SUBMITTER: Ren M 

PROVIDER: S-EPMC3368885 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.

Ren Mingqiang M   Tidwell Josephine A JA   Sharma Suash S   Cowell John K JK  

PloS one 20120606 6


Constitutive activation of FGFR1, through rearrangement with various dimerization domains, leads to atypical myeloproliferative disorders where, although T cell lymphoma are common, the BCR-FGFR1 chimeric kinase results in CML-like leukemia. As with the human disease, mouse bone marrow transduction/transplantation with BCR-FGFR1 leads to CML-like myeloproliferation as well as B-cell leukemia/lymphoma. The murine disease described in this report is virtually identical to the human disease in that  ...[more]

Similar Datasets

| S-EPMC3128478 | biostudies-literature
| S-EPMC7133745 | biostudies-literature
| S-EPMC5895858 | biostudies-other
| S-EPMC7757083 | biostudies-literature
| S-EPMC2518897 | biostudies-other
2010-05-01 | GSE15811 | GEO
2010-05-27 | E-GEOD-15811 | biostudies-arrayexpress
| S-EPMC8102549 | biostudies-literature
| S-EPMC524218 | biostudies-literature
| S-EPMC3551963 | biostudies-literature